The World Health Organization (WHO) has warned that antimicrobial resistance could cause 39 million deaths over the next 25 years, threatening the safety of routine medical procedures, surgery and childbirth.
Senior officials of the UN health agency say global efforts to prevent drug-resistant infections, improve diagnosis and promote the appropriate use of antibiotics remain too slow to meet international targets.
Acting Director of WHO’s Antimicrobial Resistance Department, Jean-Pierre Nyemazi, described the growing threat as a major challenge to modern medicine.
“Antibiotic resistance – but broadly, we are talking about antimicrobial resistance, or AMR – is widespread and threatening the future of modern medicine,” Nyemazi told a virtual conference of the 6th Annual Global Media Forum on AMR on Monday.
He warned that drug-resistant infections had continued to claim lives without attracting the level of attention given to other major health threats.
“Unlike COVID-19, which was very visible, drug-resistant infections have been taking people’s lives for years without us noticing it and raising the alarm as we should,” he said.
According to WHO figures, antimicrobial resistance was directly responsible for more than one million deaths in 2021 and associated with approximately 4.7 million additional deaths.
An assessment of efforts to combat antimicrobial resistance across 183 countries this year found that nearly nine in 10 countries had developed national action plans to address the problem.
This represents an improvement from 2017, when only about four in 10 countries had such plans.
However, WHO’s AMR Technical Officer, Pravasha Prakash, said implementation remained a major challenge, with only 42 countries, representing less than one in five, having plans that were financed, implemented and monitored.
“Countries are moving forward in every step, but progress still needs to be speeded up to reach the 2030 targets,” she said.
The agency’s latest global surveillance data also revealed that one in every six laboratory-confirmed bacterial infections reported to WHO in 2023 was resistant to the antibiotics used to treat it.
WHO’s Head of AMR Surveillance, Sylvia Bertagnolo, stressed the importance of improving diagnostic testing to ensure patients receive appropriate treatment.
“Without testing, clinicians must treat without knowing the cause of infection or which antibiotic will work,” she said.
WHO Introduces New Diagnostic Tools
To strengthen countries’ ability to identify and monitor drug-resistant infections, WHO announced the release of two new diagnostic tools.
The first outlines the essential tests that should be available at every level of healthcare delivery, from primary healthcare centres to referral hospitals.
The second provides a collection of 73 laboratory procedures covering the entire diagnostic process, including sample collection, pathogen identification and antibiotic susceptibility testing.
The agency also identified infection prevention, vaccination, improved access to clean water and sanitation, and the responsible use of antimicrobial medicines as key measures for tackling antimicrobial resistance.
WHO warned that without faster progress in these areas, the growing threat of drug-resistant infections could undermine decades of medical advances and make previously treatable infections increasingly difficult to manage.
Faridah Abdulkadiri
Follow us on:
